SLC15A3
Solute carrier family 15 member 3
Also known as: hPTR3, PHT2, S15A3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IY34
- Gene
- SLC15A3
- Ensembl
- ENSG00000110446
- Chromosome
- 11
- Canonical length
- 581 aa
- Protein class
- Metabolic proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Vesicles
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Enables dipeptide transmembrane transporter activity. Involved in dipeptide import across plasma membrane. Located in intracellular membrane-bounded organelle. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
581 residues, UniProt reviewed canonical sequence.
>Q8IY34|SLC15A3
1 MPAPRAREQP RVPGERQPLL PRGARGPRRW RRAAGAAVLL VEMLERAAFF GVTANLVLYL
61 NSTNFNWTGE QATRAALVFL GASYLLAPVG GWLADVYLGR YRAVALSLLL YLAASGLLPA
121 TAFPDGRSSF CGEMPASPLG PACPSAGCPR SSPSPYCAPV LYAGLLLLGL AASSVRSNLT
181 SFGADQVMDL GRDATRRFFN WFYWSINLGA VLSLLVVAFI QQNISFLLGY SIPVGCVGLA
241 FFIFLFATPV FITKPPMGSQ VSSMLKLALQ NCCPQLWQRH SARDRQCARV LADERSPQPG
301 ASPQEDIANF QVLVKILPVM VTLVPYWMVY FQMQSTYVLQ GLHLHIPNIF PANPANISVA
361 LRAQGSSYTI PEAWLLLANV VVVLILVPLK DRLIDPLLLR CKLLPSALQK MALGMFFGFT
421 SVIVAGVLEM ERLHYIHHNE TVSQQIGEVL YNAAPLSIWW QIPQYLLIGI SEIFASIPGL
481 EFAYSEAPRS MQGAIMGIFF CLSGVGSLLG SSLVALLSLP GGWLHCPKDF GNINNCRMDL
541 YFFLLAGIQA VTALLFVWIA GRYERASQGP ASHSRFSRDR GLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC15A3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 12
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 47 nTPM
Expression across tissuesHPA
Tissue
- spleen: 47 nTPM
- lung: 43 nTPM
- lymph node: 38 nTPM
- bone marrow: 33 nTPM
- appendix: 29 nTPM
- placenta: 26 nTPM
Single-cell type
- neutrophils: 238 nCPM
- müller glia: 205 nCPM
- schwann cells: 142 nCPM
- monocytes: 125 nCPM
- hofbauer cells: 117 nCPM
- kupffer cells: 88 nCPM
Immune cell
- neutrophil: 13 nTPM
- intermediate monocyte: 13 nTPM
- plasmacytoid DC: 11 nTPM
- classical monocyte: 9 nTPM
- myeloid DC: 6.5 nTPM
- non-classical monocyte: 6.4 nTPM
Brain region
- white matter: 19 nTPM
- medulla oblongata: 17 nTPM
- thalamus: 17 nTPM
- spinal cord: 16 nTPM
- hypothalamus: 15 nTPM
- choroid plexus: 14 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.37
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.17
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- dipeptide import across plasma membrane
- innate immune response
- monoatomic ion transport
- peptidoglycan transport
- positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway
- protein transport
Molecular functions
- dipeptide transmembrane transporter activity
- peptide:proton symporter activity
- peptidoglycan transmembrane transporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC15A3 as an antibody target. Whether an autoantibody or antibody against SLC15A3 could matter depends on whether native SLC15A3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC15A3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SLC15A3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...